The use of nanoparticles for gene therapy in the nervous system

J Alzheimers Dis. 2012;31(4):697-710. doi: 10.3233/JAD-2012-120661.

Abstract

Nanoparticles represent an alternative to viral vectors for genetic material transfer to the nervous system. However, to increase transfection efficiency in the central nervous system and to decrease toxicity, the design of nanoparticles needs to be improved to enhance blood-brain barrier crossing and endosomal escape. This paper reviews the strategies used to solve these difficulties and covers the use of various nanoparticles including natural inorganic particles, natural polymers, cationic lipids, polyethylenimine derivatives, dendrimers, and carbon-based nanoparticles. The effectiveness, both in vivo and in vitro, of each method to deliver genetic material to neural tissue is discussed.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Blood-Brain Barrier / drug effects
  • Blood-Brain Barrier / metabolism
  • Central Nervous System / drug effects
  • Central Nervous System / metabolism
  • Genetic Therapy / methods*
  • Humans
  • Nanoparticles / administration & dosage*
  • Nanoparticles / therapeutic use*
  • Nervous System Diseases / drug therapy*
  • Nervous System Diseases / genetics*
  • Nervous System Diseases / metabolism